Results 151 to 160 of about 6,002 (227)

Recurrent adenoid cystic carcinoma of the vulva: A case report of salvage stereotactic ablative radiotherapy to the pudendal nerve. [PDF]

Radiol Case Rep
Irfan H, Ben-Tarifite Y, Mahmood R.
europepmc   +1 more source

Radiotherapy commissioning and tariff-how can we deliver advanced, innovative, and personalised radiotherapy? [PDF]

Br J Radiol
Powell Brown I, Hutton D, Thorp N, Thomson J, MacKay R, Hacker L, Ashmore L, Hayes J, Archer J, Rowbottom C.   +9 more
europepmc   +1 more source

EP-1388 SABR Following Pneumonectomy: A Systematic Review of Clinical and Toxicity Outcomes

, 2019
Alexander V. Louie, Azahar Yaakub Ariffin, Faiez Al-Shafa, Gabriel Boldt, A. Warner, George Rodrigues, David A. Palma   +6 more
openalex   +1 more source

Response of non-small cell lung cancer harboring different epidermal growth factor receptor mutations to ablative radiotherapy. [PDF]

Transl Lung Cancer Res
Al Rabea A, Gerard IJ, Daniel P, Camilleri-Broët S, Oweida A, Sabri S, Abdulkarim B.   +6 more
europepmc   +1 more source

Stereotactic ablative body radiation therapy for treatment of ultra-central lung tumors: a narrative review. [PDF]

J Thorac Dis
Sun L, Tao D, Xie Y, Wang C, Zhou W, Wu Y.   +5 more
europepmc   +1 more source

Re-irradiation of recurrent lung tumours: Associations between dose and 2-year survival. [PDF]

Clin Transl Radiat Oncol
Rulach R, Harrow S, Chalmers AJ, Fenwick J.   +3 more
europepmc   +1 more source

Changes in splenic volumes following stereotactic ablative radiotherapy (SABR) to adrenal tumors. [PDF]

Clin Transl Radiat Oncol
Giraud N, Palacios MA, van Sornsen de Koste JR, Marzo AM, van Rossum PSN, Schneiders FL, Senan S.   +6 more
europepmc   +1 more source

SABR VA CHIDAMGA OID FRAZEOLOGIK BIRLIKLARNING SEMANTIK TAHLILI (INGLIZ VA OʻZBEK TILLARI MISOLIDA)

Sarvinoz Raxmanova
openalex   +2 more sources

Radiotherapy quality assurance program of ongoing clinical trial using stereotactic ablative radiation therapy for recurrent ovarian cancer (SABR-ROC): a dummy run study of a prospective, randomized, multicenter phase III trial (KGOG 3064/KROG 2204). [PDF]

BMC Cancer
Park S, Kim H, Wee CW, Kim YS, Choi JH, Kim YS, Lee JH, Choi Y, Kim JH, Cho Y, Kim HJ, Park YJ, Park W, Eom KY, Kim YH, Kim YB.   +15 more
europepmc   +1 more source

Impact of the R.E.N.A.L. complexity score on outcomes of stereotactic ablative body radiotherapy for primary renal cell carcinoma. [PDF]

BJU Int
Ali M, Bressel M, Chang D, Oon SF, Ravi R, Moon D, Murphy DG, Eapen RS, Perera M, Lawrentschuk N, Azad AA, Chander S, Shaw M, Hardcastle N, Siva S.   +14 more
europepmc   +1 more source